Home2018-07-06T19:34:27+00:00

CHS 2017 Annual Report

The year 2017 was a remarkable one. Together, we have made noteworthy advancements
towards our vision for the inherited bleeding disorder community. 

LEARN MORE

Hemophilia Today

Check out the latest issue of the CHS’ newsmagazine, Hemophilia Today, for information, current news and issues relevant to the bleeding disorder community.

LEARN MORE

MyCBDR

MyCBDR is the system used by patients and/or their caregivers who are on home treatment. It is linked directly to the CBDR at your treatment centre.

LEARN MORE

Research and market studies

Please take the time to see what is presently happening with regards to research and market studies and to see if you could take an active part in them. 

LEARN MORE

STRATEGIC PLAN  |  2016‐2020

LEARN MORE

Deaths of patients receiving emicizumab judged unrelated to drug

MONTREAL – March 29, 2018 – On March 29, 2018, following considerable social media activity, Roche released a statement on the deaths of five patients who had been receiving emicizumab.

Learn more

Q&A about RFPs

We often receive questions about the tender process (RFP) for clotting factor concentrates. We produced a Q&A document which we hope will answer all your questions on the topic.

Learn more

Recombinant factor concentrate charts

Please check out our updated charts listing the recombinant factor concentrates and their description.

Click here for the rFVIII chart

Click here for the rFIX chart

REACH US AT

1-800-668-2686

chs@hemophilia.ca

WE’RE HERE TO HELP.

CONTACT US

FIND A TREATMENT CENTRE NEAR YOU

SEARCH